Recent study identified a two-lncRNA signature (ILF3-AS1 and RASA4CP) as an independent biomarker which could predict the prognosis of cervical cancer based on the TCGA database and quantitative reverse transcription PCR (qRT-PCR) (Wu et al., 2019). The gene discussed is RASA4CP; the disease is cervical carcinoma.